Limited-stage Small-cell Lung Cancer trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Limited-stage Small-cell Lung Cancer trials nationally

Cities in Illinois

Recruiting trials in Illinois

• BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
  NCT06773910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Arlington Heights, Peoria